Langvarig virkning synes at være mere sandsynlig hos patienter, hvis nevirapine through niveauer overstiger 3, 5 µg/ ml.
Long-term efficacy appears to be most likely in patients whose nevirapine trough levels exceed 3.5 µg/ ml.